Top Markets
#1 Islamic Coin Islamic Coin +154.39%
#2 PulseChain PulseChain +49.22%
#3 BOOK OF MEME BOOK OF MEME +27.67%
#4 Starpower Starpower +17.49%
#5 RedStone RedStone +17.36%
#6 edgeX edgeX +14.39%
#7 Lighter Lighter +12.26%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.08%
#9 Monad Monad +10.74%
#10 Bio Protocol Bio Protocol +9.97%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Lite Strategy, Inc. Lite Strategy, Inc.

Lite Strategy, Inc.

LITS
Rank in Stocks #27541
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm,... Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Share Price
$0.9474
Last synced: 2026-08-19
Market Cap
$32.24M
Change (1 day)
7.41%
Change (1 year)
-
Country
US
Trade Lite Strategy, Inc. (LITS)

Category

Healthcare
Revenue for Lite Strategy, Inc. (LITS)
Revenue in Aug 2026 TTM: 0
According to Lite Strategy, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Lite Strategy, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH